Toward an MRI-based nomogram for the prediction of transperineal prostate biopsy outcome: A physician and patient decision tool
Authors:
Open Access
- 1 November 2017
- journal article
- Published by Elsevier in Urologic Oncology: Seminars and Original Investigations
- Vol. 35 (11) , 664.e11-664.e18
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Identification of pathologically insignificant prostate cancer is not accurate in unscreened menBritish Journal of Cancer, 2014
- Risk of repeat biopsy and prostate cancer detection after an initial extended negative biopsy: longitudinal follow‐up from a prospective trialBJU International, 2013
- Analysis of Preoperative Detection for Apex Prostate Cancer by Transrectal BiopsyProstate Cancer, 2013
- Short term outcomes of prostate biopsy in men tested for cancer by prostate specific antigen: prospective evaluation within ProtecT studyBMJ, 2012
- Development of Improved Nomogram for Prediction of Outcome of Initial Prostate Biopsy Using Readily Available Clinical InformationUrology, 2011
- Prostate Cancer Detection Rate in Patients with Repeated Extended 21-Sample Needle BiopsyEuropean Urology, 2009
- Assessing Individual Risk for Prostate CancerJournal of Clinical Oncology, 2007
- Development and External Validation of an Extended 10-Core Biopsy NomogramEuropean Urology, 2007
- The clinical features of anterior prostate cancersBJU International, 2006
- Lead Times and Overdetection Due to Prostate-Specific Antigen Screening: Estimates From the European Randomized Study of Screening for Prostate CancerJNCI: Journal of the National Cancer Institute, 2003